228 related articles for article (PubMed ID: 3566714)
1. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
Kontoghiorghes GJ; Chambers S; Hoffbrand AV
Biochem J; 1987 Jan; 241(1):87-92. PubMed ID: 3566714
[TBL] [Abstract][Full Text] [Related]
2. Iron release from haemosiderin and ferritin by therapeutic and physiological chelators.
O'Connell MJ; Ward RJ; Baum H; Peters TJ
Biochem J; 1989 Jun; 260(3):903-7. PubMed ID: 2764911
[TBL] [Abstract][Full Text] [Related]
3. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
Kontoghiorghes GJ; Barr J; Nortey P; Sheppard L
Am J Hematol; 1993 Apr; 42(4):340-9. PubMed ID: 8493983
[TBL] [Abstract][Full Text] [Related]
4. Iron mobilization from ferritin using alpha-oxohydroxy heteroaromatic chelators.
Kontoghiorghes GJ
Biochem J; 1986 Jan; 233(1):299-302. PubMed ID: 3954731
[TBL] [Abstract][Full Text] [Related]
5. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
Brock JH; Licéaga J; Arthur HM; Kontoghiorghes GJ
Am J Hematol; 1990 May; 34(1):21-5. PubMed ID: 2327400
[TBL] [Abstract][Full Text] [Related]
6. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
[TBL] [Abstract][Full Text] [Related]
7. Studies on haemosiderin and ferritin from iron-loaded rat liver.
Andrews SC; Brady MC; Treffry A; Williams JM; Mann S; Cleton MI; de Bruijn W; Harrison PM
Biol Met; 1988; 1(1):33-42. PubMed ID: 3152870
[TBL] [Abstract][Full Text] [Related]
8. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism?
O'Connell M; Halliwell B; Moorhouse CP; Aruoma OI; Baum H; Peters TJ
Biochem J; 1986 Mar; 234(3):727-31. PubMed ID: 3718494
[TBL] [Abstract][Full Text] [Related]
9. Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox.
Rakba N; Aouad F; Henry C; Caris C; Morel I; Baret P; Pierre JL; Brissot P; Ward RJ; Lescoat G; Crichton RR
Biochem Pharmacol; 1998 Jun; 55(11):1797-806. PubMed ID: 9714298
[TBL] [Abstract][Full Text] [Related]
10. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.
Kontoghiorghes GJ; Sheppard L; Chambers S
Arzneimittelforschung; 1987 Oct; 37(10):1099-102. PubMed ID: 3435580
[TBL] [Abstract][Full Text] [Related]
11. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
[TBL] [Abstract][Full Text] [Related]
12. Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay.
Anderson D; Yardley-Jones A; Vives-Bauza C; Chua-Anusorn W; Cole C; Webb J
Teratog Carcinog Mutagen; 2000; 20(5):251-64. PubMed ID: 10992272
[TBL] [Abstract][Full Text] [Related]
13. Ferritin iron minerals are chelator targets, antioxidants, and coated, dietary iron.
Theil EC
Ann N Y Acad Sci; 2010 Aug; 1202():197-204. PubMed ID: 20712793
[TBL] [Abstract][Full Text] [Related]
14. Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators.
Kontoghiorghes GJ; Evans RW
FEBS Lett; 1985 Sep; 189(1):141-4. PubMed ID: 4029396
[TBL] [Abstract][Full Text] [Related]
15. Mössbauer spectroscopic studies of deproteinised, sub-fractionated and reconstituted ferritins: the relationship between haemosiderin and ferritin.
St Pierre TG; Pollard RK; Dickson DP; Ward RJ; Peters TJ
Biochim Biophys Acta; 1988 Jan; 952(2):158-63. PubMed ID: 3337822
[TBL] [Abstract][Full Text] [Related]
16. Iron K-edge absorption spectroscopic investigations of the cores of ferritin and haemosiderins.
Mackle P; Garner CD; Ward RJ; Peters TJ
Biochim Biophys Acta; 1991 Dec; 1115(2):145-50. PubMed ID: 1764466
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and iron(III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid.
Molenda JJ; Basinger MA; Hanusa TP; Jones MM
J Inorg Biochem; 1994 Aug; 55(2):131-46. PubMed ID: 8051541
[TBL] [Abstract][Full Text] [Related]
18. Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte.
Mostert LJ; Van Dorst JA; Koster JF; Van Eijk HG; Kontoghiorghes GJ
Free Radic Res Commun; 1987; 3(6):379-88. PubMed ID: 3508452
[TBL] [Abstract][Full Text] [Related]
19. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.
Porter JB; Gyparaki M; Burke LC; Huehns ER; Sarpong P; Saez V; Hider RC
Blood; 1988 Nov; 72(5):1497-503. PubMed ID: 3179437
[TBL] [Abstract][Full Text] [Related]
20. Fast biological iron chelators: kinetics of iron removal from human diferric transferrin by multidentate hydroxypyridonates.
Turcot I; Stintzi A; Xu J; Raymond KN
J Biol Inorg Chem; 2000 Oct; 5(5):634-41. PubMed ID: 11085654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
